跳至主要内容
临床试验/DRKS00026962
DRKS00026962已完成未知

Proof of concept study to investigate bioavailability of two different Curcumin formulations in healthy subjects: a randomized, controlled, cross-over study

nternehmen zur Herstellung und Vertrieb von Nahrungsergänzungsmitteln0 个研究点目标入组 6 人开始时间: 2021年10月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 65 Years(—)
性别
All

入选标准

  • Healthy men and women
  • - BMI: 19 - 30 kg/m2
  • - Non-smoker
  • - Written consent to participate in the study
  • - Able and willing to follow the study procedure

排除标准

  • Main exclusion criteria:
  • - Relevant history or presence of any severe medical disorder, potentially interfering with this study
  • - Known allergy and hypersensitivity to ingredients of the study product
  • - Blood donation within 1 month prior to study start or during study
  • - Significant changes in lifestyle or medication (within last 3 months) or surgical intervention or surgical procedure such as bariatric surgery
  • - For this study clinically relevant abnormal laboratory, vital signs or physical findings at screening
  • - Extreme dietary regimes”: vegan lifestyle, weight loss diet with <1200 kcal/day for women and <1800 kcal for men
  • - Regular intake of drugs or supplements possibly interfering with this study within 2 weeks prior to study start or during the study (e.g. curcumin)
  • - Chronic intake of substances affecting blood coagulation, which in the investigator’s opinion would impact subject safety
  • - Subjects with history of drug, alcohol or other substance abuse, or other factors limiting their ability to co-operate during the study.
  • - Known pregnancy, breast feeding or intention to become pregnant during the study.
  • - Anticipating any planned changes in lifestyle for the duration of the study

研究者

发起方
nternehmen zur Herstellung und Vertrieb von Nahrungsergänzungsmitteln

相似试验